DMG Mori (6141) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
30 Oct, 2026Executive summary
Jan–Sep orders reached a record JPY 522.0bn, up 36.7% YoY; sales revenue rose 23.2% to JPY 422.706bn and operating profit increased 46.3% to JPY 16.876bn.
Machine order backlog reached JPY 328.0bn at September-end; FY2026 order intake guidance rose to more than JPY 650bn, with backlog expected to support FY2027 and FY2028 sales growth.
Financial highlights
Jan–Sep EBITDA was JPY 44.9bn, up 22.8% YoY; EBITDA margin was 10.6%, while operating margin improved to 4.0% from 3.4%.
Parent-attributable profit was JPY 8.668bn versus JPY 21.002bn; prior-year results included JPY 16.875bn of insurance proceeds from discontinued operations.
Profit before income taxes was JPY 11.939bn versus JPY 23.705bn.
Jul–Sep revenue increased 26.2% YoY; EBIT rose 50.5% and EBIT margin improved to 5.2% from 4.3%.
Operating cash flow was JPY 39.875bn versus cash used of JPY 0.203bn; investing and financing cash outflows were JPY 18.035bn and JPY 25.609bn.
Outlook and guidance
FY2026 order intake forecast rose from JPY 630bn to more than JPY 650bn; revenue is forecast at JPY 580bn, operating profit at JPY 30bn and parent-attributable profit at JPY 15.5bn.
FY2026 EBITDA forecast is JPY 67bn with an 11.6% margin; operating margin is forecast at 5.2%, and basic EPS at JPY 89.12.
FY2027 plan includes JPY 630bn revenue, JPY 88bn EBITDA and an 8.1% EBIT margin; backlog is expected to support sales growth in FY2027 and FY2028.
Operating free cash flow is projected at JPY 30bn for FY2026 versus JPY 14.8bn in FY2025; FY2027 dividend per share is planned at JPY 110.
FY2026 forecast exchange-rate assumptions are JPY 157.7/$ and JPY 181.8/€; actual results may differ as circumstances change.
Latest events from DMG Mori
- Record H1 2026 order and revenue growth led to upward revisions in full-year guidance.6141
Q2 2026 - Record order intake and profit growth led to an upward revision of FY2026 guidance.6141
Q1 2026 - FY2025 saw order and profit recovery, but FY2026 profit is set to drop sharply with stable dividends.6141
Q4 2025 - Order intake steady, sales and EBIT down, net profit rebounded on insurance proceeds.6141
Q3 2025 - Order intake and average order price rose, but sales and profits declined sharply year-over-year.6141
Q2 2025 - Net profit collapsed on Russian exit, prompting lower full-year guidance despite stable sales.6141
Q3 2024 - Upward order revision and margin gains signal strong growth despite one-time Russian loss.6141
Q2 2024 - Profit and revenue declined, but order intake and sustainability efforts support recovery.6141
Q1 2025 - Profits fell sharply in FY2024, but automation and new initiatives drive future growth.6141
Q4 2024